Ligand validation:6H0B

NGA: 2-acetamido-2-deoxy-beta-D-galactopyranose

NGA is a Ligand Of Interest in 6H0B designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6H0B_NGA_F_101	52%	52%	0.188	0.946	0.87	0.98	-	-	0	1	100%	0.9333
6H0B_NGA_F_102	33%	59%	0.206	0.884	0.49	1.07	-	2	1	1	100%	0.9333
6S24_NGA_F_101	62%	53%	0.119	0.91	0.64	1.18	-	2	0	1	100%	0.9333
5NQA_NGA_A_644	52%	6%	0.174	0.931	1.49	3.5	2	5	2	0	100%	1
5T52_NGA_A_303	97%	32%	0.065	0.982	0.9	1.78	1	5	0	0	100%	1
1WMZ_NGA_C_503	95%	15%	0.059	0.96	1.07	2.63	1	11	0	0	100%	1
2Z48_NGA_A_1003	93%	56%	0.067	0.963	0.55	1.15	-	2	0	0	100%	1
6S22_NGA_F_201	93%	45%	0.069	0.964	1.12	1	1	-	0	1	100%	0.9333
3GH7_NGA_A_1300	93%	28%	0.088	0.982	0.85	2.01	1	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.